コンテンツへスキップ
Merck
  • Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study.

Clopidogrel bioactivation and risk of bleeding in patients cotreated with angiotensin-converting enzyme inhibitors after myocardial infarction: a proof-of-concept study.

Clinical pharmacology and therapeutics (2014-09-16)
K E Kristensen, H-J Zhu, X Wang, G H Gislason, C Torp-Pedersen, H B Rasmussen, J S Markowitz, P R Hansen
要旨

Clopidogrel is an oral antiplatelet prodrug, the majority of which is hydrolyzed to an inactive metabolite by hepatic carboxylesterase 1 (CES1). Most angiotensin-converting enzyme inhibitors (ACEIs) are also metabolized by this enzyme. We examined the effects of ACEIs on clopidogrel bioactivation in vitro and linked the results with a pharmacoepidemiological study. In vitro, ACEIs inhibited CES1-mediated hydrolysis of a model substrate, and trandolapril and enalapril increased formation of clopidogrel active metabolite. In 70,934 patients with myocardial infarction, hazard ratios for clinically significant bleeding in ACEI-treated patients cotreated with or without clopidogrel were 1.10 (95% confidence interval (CI): 0.97-1.25, P = 0.124) and 0.90 (95% CI: 0.81-0.99, P = 0.025), respectively, as compared with patients who did not receive ACEIs. This difference was statistically significant (P = 0.002). We conclude that cotreatment with selected ACEIs and clopidogrel may increase the risk of bleeding. Combination of in vitro and pharmacoepidemiological studies may be a useful paradigm for assessment of drug-drug interactions.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
4-ニトロフェノール, ReagentPlus®, ≥99%
Sigma-Aldrich
エステラーゼ ブタ肝臓由来, lyophilized powder, ≥15 units/mg solid
Sigma-Aldrich
4-ニトロフェノール 溶液, 10 mM
Sigma-Aldrich
エステラーゼ ブタ肝臓由来, ammonium sulfate suspension, ≥150 units/mg protein (biuret)
Sigma-Aldrich
エステラーゼ Bacillus subtilis(枯草菌)由来, recombinant, expressed in E. coli, ≥10 U/mg
Sigma-Aldrich
Ramipril, ≥98% (HPLC)
Sigma-Aldrich
2-ブロモ-3′-メトキシアセトフェノン, 98%
Sigma-Aldrich
4-ニトロフェノール, spectrophotometric grade
Sigma-Aldrich
エステラーゼ from rabbit liver, lyophilized powder, ≥30 units/mg protein
Sigma-Aldrich
エステラーゼ Bacillus stearothermophilus由来, recombinant, expressed in E. coli, ≥4.0 U/mg
Sigma-Aldrich
エステラーゼ Bacillus stearothermophilus由来, ≥0.2 U/mg
Sigma-Aldrich
Perindopril erbumine
USP
エナラプリル マレイン酸塩, United States Pharmacopeia (USP) Reference Standard
Supelco
4-ニトロフェノール, PESTANAL®, analytical standard
USP
Ramipril, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Esterase Pseudomonas fluorescens, recombinant 大腸菌由来, ≥4 U/mg
Sigma-Aldrich
ホシノプリル ナトリウム, ≥98% (HPLC), powder
Sigma-Aldrich
Esterase Isoenzyme 1 porcine liver, recombinant, recombinant, expressed in E. coli, ≥30.0 U/g
Supelco
チクロピジン 塩酸塩, analytical standard, for drug analysis
Supelco
Ramipril, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
4-ニトロフェノール, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
エナラプリル マレイン酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
USP
ホシノプリル ナトリウム, United States Pharmacopeia (USP) Reference Standard
エナラプリル マレイン酸塩, European Pharmacopoeia (EP) Reference Standard
Perindopril erbumine, European Pharmacopoeia (EP) Reference Standard
Perindopril erbumine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
モエキシプリル 塩酸塩, powder, ≥98% (HPLC)
Ramipril, European Pharmacopoeia (EP) Reference Standard
Perindopril erbumine, European Pharmacopoeia (EP) Reference Standard
ホシノプリル ナトリウム, European Pharmacopoeia (EP) Reference Standard